Surgical Management of Gastroesophageal Reflux Disease in Patients with Severe Esophageal Dysmotility.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
01 2019
Historique:
received: 21 06 2018
accepted: 09 09 2018
pubmed: 6 10 2018
medline: 27 2 2020
entrez: 6 10 2018
Statut: ppublish

Résumé

Gastroesophageal reflux disease (GERD) and esophageal dysmotility are often disqualifying criteria for fundoplication due to dysphagia complications. A tailored partial fundoplication may improve GERD in patients with severe esophageal motility disorders. We evaluate this approach on GERD improvement in non-achalasia esophageal dysmotility patients. A single-institution prospective database was reviewed (2007-2016), with inclusion criteria of GERD, previous diagnosis of non-achalasia esophageal motility disorder, and laparoscopic partial fundoplication. Diagnosis of previous achalasia diagnosis or diffused esophageal spasm was excluded. Motility studies, pre- and post-upper gastrointestinal imaging (UGI), esophageal symptom scores, antacid, and PPI use were collected pre-op, 6 months, 12 months, and long-term (LT). Statistical analysis was made using SPSS v.23.0.0, α = 0.05. Fifty-two patients met the inclusion criteria. A total of 17.3% had esophageal body amotility, 79.6% had severe esophageal dysmotility. A total of 65.9% women (mean age 64 ± 15.7), mean peristalsis 45.3 ± 32.6%, and failed peristalsis 36.0 ± 32.2%. Mean LES residual pressure was 15.0 ± 18.0 mmHg, and 40.7% had hypotensive LES. Mean follow-up time was 25 months [1-7 years], with significant improvement in symptoms and reduction in PPI and antacid use at all time-points compared to pre-op. A total of 74% had UGI studies at 12 months; all showed persistent dysmotility. Six patients had radiographic hiatal hernia recurrence, with only one being clinically symptomatic postoperatively. Three required dilation for persistent dysphagia. A tailored partial fundoplication may be effective in symptom relief for non-achalasia patients with esophageal motility disorders and GERD. Significant symptom improvement, low HHR, and PPI use clearly indicate this approach to be effective for this population.

Sections du résumé

BACKGROUND
Gastroesophageal reflux disease (GERD) and esophageal dysmotility are often disqualifying criteria for fundoplication due to dysphagia complications. A tailored partial fundoplication may improve GERD in patients with severe esophageal motility disorders. We evaluate this approach on GERD improvement in non-achalasia esophageal dysmotility patients.
METHODS
A single-institution prospective database was reviewed (2007-2016), with inclusion criteria of GERD, previous diagnosis of non-achalasia esophageal motility disorder, and laparoscopic partial fundoplication. Diagnosis of previous achalasia diagnosis or diffused esophageal spasm was excluded. Motility studies, pre- and post-upper gastrointestinal imaging (UGI), esophageal symptom scores, antacid, and PPI use were collected pre-op, 6 months, 12 months, and long-term (LT). Statistical analysis was made using SPSS v.23.0.0, α = 0.05.
RESULTS
Fifty-two patients met the inclusion criteria. A total of 17.3% had esophageal body amotility, 79.6% had severe esophageal dysmotility. A total of 65.9% women (mean age 64 ± 15.7), mean peristalsis 45.3 ± 32.6%, and failed peristalsis 36.0 ± 32.2%. Mean LES residual pressure was 15.0 ± 18.0 mmHg, and 40.7% had hypotensive LES. Mean follow-up time was 25 months [1-7 years], with significant improvement in symptoms and reduction in PPI and antacid use at all time-points compared to pre-op. A total of 74% had UGI studies at 12 months; all showed persistent dysmotility. Six patients had radiographic hiatal hernia recurrence, with only one being clinically symptomatic postoperatively. Three required dilation for persistent dysphagia.
CONCLUSIONS
A tailored partial fundoplication may be effective in symptom relief for non-achalasia patients with esophageal motility disorders and GERD. Significant symptom improvement, low HHR, and PPI use clearly indicate this approach to be effective for this population.

Identifiants

pubmed: 30288691
doi: 10.1007/s11605-018-3968-6
pii: 10.1007/s11605-018-3968-6
doi:

Substances chimiques

Antacids 0
Proton Pump Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-42

Références

Surg Endosc. 2008 Jan;22(1):21-30
pubmed: 18027055
J Gastrointest Surg. 2002 Jan-Feb;6(1):22-7; discussion 27-8
pubmed: 11986014
Surg Clin North Am. 2015 Jun;95(3):467-82
pubmed: 25965124
J Gastrointest Surg. 2017 Sep;21(9):1544-1552
pubmed: 28623447
Ann Surg. 2017 Jul;266(1):23-28
pubmed: 28294958
Gastroenterology. 2018 Jan;154(2):267-276
pubmed: 28780072
J Gastrointest Surg. 1999 Nov-Dec;3(6):583-91
pubmed: 10554364
Surg Endosc. 2007 Feb;21(2):285-8
pubmed: 17122978
Gastroenterology. 2001 Jul;121(1):5-14
pubmed: 11438489
J Gastrointest Surg. 1997 Jul-Aug;1(4):301-8; discussion 308
pubmed: 9834362
J Gastrointest Surg. 2014 Oct;18(10):1723-9
pubmed: 25091845
Am Surg. 2018 Apr 1;84(4):481-488
pubmed: 29712593
Gut. 1997 Mar;40(3):381-5
pubmed: 9135529
Br J Surg. 1998 Sep;85(9):1290-3
pubmed: 9752880
Surg Endosc. 2002 Jun;16(6):909-13
pubmed: 12163953
Gut. 1995 Sep;37(3):305-8
pubmed: 7590421
Surg Endosc. 2018 Apr;32(4):1668-1674
pubmed: 29046957
BMC Gastroenterol. 2016 Aug 02;16(1):88
pubmed: 27484006
Surg Laparosc Endosc Percutan Tech. 2017 Feb;27(1):24-29
pubmed: 28145965
Surg Endosc. 2018 Sep;32(9):3855-3860
pubmed: 29435755
Br J Surg. 2017 Jun;104(7):843-851
pubmed: 28295217
Dig Surg. 2011;28(1):80-6
pubmed: 21293136
Einstein (Sao Paulo). 2016 Jul-Sep;14(3):439-442
pubmed: 26958977
Surg Obes Relat Dis. 2017 Apr;13(4):547-552
pubmed: 27889485
Surgery. 2017 Apr;161(4):977-983
pubmed: 28011013
J Gastrointest Surg. 2014 Jan;18(1):157-62; discussion 162-3
pubmed: 24234243
Dig Surg. 2014;31(4-5):354-8
pubmed: 25503359

Auteurs

Priscila R Armijo (PR)

Center for Advanced Surgical Technology, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA.

Dietric Hennings (D)

Center for Advanced Surgical Technology, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA.
Department of Surgery, University of Nebraska Medical Center, 986245 Nebraska Medical Center, Omaha, NE, 68198-6245, USA.

Melissa Leon (M)

Center for Advanced Surgical Technology, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA.

Akshay Pratap (A)

Center for Advanced Surgical Technology, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA.
Department of Surgery, University of Nebraska Medical Center, 986245 Nebraska Medical Center, Omaha, NE, 68198-6245, USA.

Austin Wheeler (A)

College of Medicine, University of Nebraska Medical Center, 986245 Nebraska Medical Center, Omaha, NE, 68198-6245, USA.

Dmitry Oleynikov (D)

Center for Advanced Surgical Technology, University of Nebraska Medical Center, 986246 Nebraska Medical Center, Omaha, NE, 68198-6246, USA. doleynik@unmc.edu.
Department of Surgery, University of Nebraska Medical Center, 986245 Nebraska Medical Center, Omaha, NE, 68198-6245, USA. doleynik@unmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH